Hepatocellular carcinoma and hepatitis B virus markers in Europe and U.S.A.
D000914:Antibodies, Viral / Q000302:isolation & purification*; D002140:California; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000209:etiology*; D002908:Chronic Disease; D006115:Greece; D006509:Hepatitis B / Q000150:complications* / Q000453:epidemiology / Q000382:microbiology; D006510:Hepatitis B Antibodies / Q000302:isolation & purification*; D006512:Hepatitis B Core Antigens / Q000302:isolation & purification*; D006514:Hepatitis B Surface Antigens / Q000302:isolation & purification*; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications; D008113:Liver Neoplasms / Q000453:epidemiology / Q000209:etiology*; D006113:United Kingdom
D000914:Antibodies, Viral; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens